Activation and methotrexate-mediated suppression of the TNFα promoter in T cells and macrophages

Annals of the New York Academy of Sciences

Volumn 859, Issue , 1998, Pages 219-222

  Becker, Christoph ^a   Barbulescu, Karina ^a   Hildner, Kai ^a   Büschenfelde, Karl Hermann Meyer Zum ^a   Neurath, Markus F ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE; TUMOR NECROSIS FACTOR ALPHA;

CONFERENCE PAPER; DNA FOOTPRINTING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MACROPHAGE; NORMAL HUMAN; T LYMPHOCYTE;

EID: 0032406597     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb11133.x     Document Type: Conference Paper

References (5)

1. 1. DI, G. N. 1997. Expression of TNF-alpha by human plasma cells in chronic inflammation. J. Leukoc. Biol. 61: 667.
2. 2. RIDDERSTAD, A. 1991. Cytokines in rheumatoid arthritis. Ann. Med. 23: 219.
3. 3. REIMUND, J. M. 1996. Increased production of tumour necrosis factor-alpha interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease. Gut 39: 684.
4. 4. MUELLER, P. R. 1989. In vivo footprinting of a muscle specific enhancer by ligation mediated PCR. Science 246: 780.
5. 5. TSAI, E. Y. 1996. Tumor necrosis factor alpha gene regulation in activated T cells involves ATF-2/Jun and NFATp. Mol. Cell Biol. 16: 459.